Bridging the quality gap in diagnosis and treatment of malaria

BMJ. 2020 Apr 22;369:m1176. doi: 10.1136/bmj.m1176.

Authors

Daniel J Ikeda¹, Roly Gosling², M James Eliades³, Amanda Chung², Joseph Murungu¹, Bruce D Agins¹

Affiliations

¹ HEALTHQUAL, Institute for Global Health Sciences, University of California, San Francisco, CA, USA.
² Malaria Elimination Initiative, Institute for Global Health Sciences, University of California, San Francisco, CA, USA.
³ Population Services International, Yangon, Myanmar.

PMID: 32321709
DOI: 10.1136/bmj.m1176

No abstract available

MeSH terms

Africa South of the Sahara
Anti-Infective Agents / therapeutic use
Antimalarials / therapeutic use*
Artemisinins / therapeutic use
Child, Preschool
Disease Eradication
Female
Health Services Accessibility*
Humans
Infant
Malaria / diagnosis*
Malaria / drug therapy*
Malaria / prevention & control
Male
Mosquito Control
Pregnancy
Pregnancy Complications, Parasitic / prevention & control
Professional Practice Gaps
Quality of Health Care*

Substances

Anti-Infective Agents
Antimalarials
Artemisinins
artemisinin